Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Esperion Therapeutics Inc (NASDAQ: ESPR) closed the day trading at $0.92 up 4.39% from the previous closing price of $0.88. In other words, the price has increased by $4.39 from its previous closing price. On the day, 4.84 million shares were traded. ESPR stock price reached its highest trading level at $0.9389 during the session, while it also had its lowest trading level at $0.8519.
Ratios:
For a better understanding of ESPR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.99 and its Current Ratio is at 1.37.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on December 18, 2024, initiated with a Neutral rating and assigned the stock a target price of $4.
On December 17, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $8.
BofA Securities Downgraded its Neutral to Underperform on June 20, 2024, while the target price for the stock was maintained at $2.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 17 ’25 when Warren Eric sold 108 shares for $0.98 per share. The transaction valued at 106 led to the insider holds 370,218 shares of the business.
Halladay Benjamin sold 8 shares of ESPR for $8 on Apr 17 ’25. The Chief Financial Officer now owns 481,702 shares after completing the transaction at $0.96 per share. On Apr 17 ’25, another insider, Halladay Benjamin, who serves as the Officer of the company, bought 8 shares for $0.96 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ESPR now has a Market Capitalization of 182297072 and an Enterprise Value of 628472000. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.55. Its current Enterprise Value per Revenue stands at 1.891 whereas that against EBITDA is 11.539.
Stock Price History:
The Beta on a monthly basis for ESPR is 0.80, which has changed by -0.53768843 over the last 52 weeks, in comparison to a change of 0.07995045 over the same period for the S&P500. Over the past 52 weeks, ESPR has reached a high of $3.94, while it has fallen to a 52-week low of $0.82. The 50-Day Moving Average of the stock is -36.47%, while the 200-Day Moving Average is calculated to be -53.27%.
Shares Statistics:
Over the past 3-months, ESPR traded about 4.51M shares per day on average, while over the past 10 days, ESPR traded about 5298730 shares per day. A total of 195.85M shares are outstanding, with a floating share count of 194.67M. Insiders hold about 1.76% of the company’s shares, while institutions hold 58.73% stake in the company. Shares short for ESPR as of 1744675200 were 30028700 with a Short Ratio of 6.66, compared to 1741910400 on 28900005. Therefore, it implies a Short% of Shares Outstanding of 30028700 and a Short% of Float of 15.22.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
